Abstract

BackgroundCorticosteroids (CCS) are a cornerstone of current treatment regimens in Systemic Lupus Erythematosus (SLE). However, increasing evidence points to their significant contribution to medium-to-long term organ damage.ObjectivesTo assess the clinical...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call